Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 544K | 544K | 544K | 2.85M | 2.85M | 2.85M | 2.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 272K | 407K | 544K | 407K | 862K | 1.22M | 1.08M | 1.42M | 1.41M | 1.36M | 1.81M | 1.67M | 1.35M | 1.03M | 685K | 356K | 220K | 98K |
Gross Profit | 272K | 137K | n/a | 2.44M | 1.98M | 1.63M | 1.76M | -1.42M | -1.41M | -1.36M | -1.81M | -1.67M | -1.35M | -1.03M | -685K | -356K | -220K | -98K |
Operating Income | -28.58M | -31.16M | -32.61M | -32.48M | -32.4M | -34.79M | -37.06M | -41.97M | -48.17M | -48.71M | -50.19M | -46.55M | -42.93M | -42M | -37.48M | -33.15M | -28.19M | -23.32M |
Interest Income | 1.84M | 2.19M | 2.55M | 2.85M | 3.14M | 3.42M | 3.62M | 3.41M | 3.04M | 2.44M | 1.78M | 1.51M | 1.27M | 1.11M | 800K | 466K | 188K | n/a |
Pretax Income | -26.82M | -29.03M | -30.16M | -29.8M | -29.67M | -31.92M | -34.1M | -38.92M | -45.21M | -46.36M | -48.59M | -45.72M | -41.99M | -41.23M | -36.79M | -32.56M | -28.24M | -23.38M |
Net Income | -26.82M | -29.03M | -30.16M | -29.8M | -29.67M | -31.92M | -34.1M | -39.13M | -44.9M | -45.87M | -48.01M | -44.94M | -41.73M | -41.15M | -36.79M | -32.56M | -28.24M | -23.38M |
Selling & General & Admin | 12.24M | 12.77M | 12.9M | 13.58M | 14.31M | 16.5M | 18.63M | 20.82M | 21.65M | 20.58M | 19.8M | 17.56M | 16.68M | 16.25M | 15.82M | 14.88M | 12.8M | 10.22M |
Research & Development | 15.38M | 17.43M | 18.63M | 18.63M | 17.81M | 18.01M | 18.3M | 21.15M | 26.52M | 28.13M | 30.38M | 28.99M | 26.25M | 25.75M | 21.66M | 18.26M | 15.39M | 12.36M |
Other Expenses | 951K | 951K | 949K | -69K | 544K | 612K | 614K | 2.25M | 1.65M | 1.58M | 1.58M | 20K | 631K | 603K | 600K | 600K | -31K | -3K |
Operating Expenses | 27.76M | 30.34M | 31.66M | 32.21M | 32.12M | 34.51M | 36.93M | 41.97M | 48.17M | 48.71M | 50.19M | 46.55M | 42.93M | 42M | 37.48M | 33.15M | 28.19M | 22.58M |
Interest Expense | 15K | 49K | 90K | 104K | 116K | 130K | 144K | 113K | 90K | 224K | 425K | 731K | 935K | 910K | 670K | 418K | 207K | 63K |
Selling & Marketing Expenses | n/a | n/a | -137K | -272K | -272K | -272K | -135K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.37M | 31.16M | 32.61M | 32.48M | 32.4M | 34.79M | 37.06M | 41.97M | 48.17M | 48.71M | 50.19M | 46.55M | 42.93M | 42M | 37.48M | 33.15M | 28.19M | 22.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 209K | -316K | -493K | -575K | -831K | -306K | -142K | -57K | -10K | -7K | 9K |
Shares Outstanding (Basic) | 1.26B | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M | 30.59M | 30.59M | 18.9M |
Shares Outstanding (Diluted) | 1.26B | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M | 30.59M | 30.59M | 18.9M |
EPS (Basic) | -4.78 | -1.15 | -1.2 | -1.19 | -1.18 | -1.21 | -1.22 | -1.32 | -1.46 | -1.49 | -1.56 | -1.47 | -1.37 | -1.35 | -1.37 | -1.33 | -1.45 | -1.53 |
EPS (Diluted) | -4.78 | -1.15 | -1.2 | -1.19 | -1.18 | -1.21 | -1.22 | -1.32 | -1.46 | -1.49 | -1.56 | -1.47 | -1.37 | -1.35 | -1.37 | -1.33 | -1.45 | -1.53 |
EBITDA | -26.54M | -28.31M | -29.32M | -28.96M | -28.69M | -30.57M | -32.52M | -37.97M | -44.29M | -45.35M | -47.29M | -43.32M | -39.7M | -39.28M | -35.44M | -31.71M | -27.68M | -23.03M |
EBIT | -21.84M | -28.95M | -30.07M | -29.7M | -29.56M | -31.79M | -33.96M | -39.01M | -45.33M | -46.34M | -48.37M | -44.99M | -41.06M | -40.32M | -36.12M | -32.14M | -28.03M | -23.32M |
Depreciation & Amortization | 471K | 799K | 936K | 932K | 1.05M | 1.22M | 1.44M | 1.77M | 1.77M | 1.72M | 1.81M | 1.67M | 1.35M | 1.03M | 685K | 426K | 354K | 284K |